Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review
It is estimated that there are over 890,000 new cases of head and neck squamous cell carcinoma (HNSCC) worldwide each year, accounting for approximately 5% of all cancer cases. Current treatment options for HNSCC often cause significant side effects and functional impairments, thus there is a challe...
Saved in:
Main Authors: | Karolina Dżaman (Author), Katarzyna Czerwaty (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Localized Drug Delivery Systems: An Update on Treatment Options for Head and Neck Squamous Cell Carcinomas
by: Arvind Hariharan, et al.
Published: (2023) -
Plasma Extracellular Vesicles-Derived miR-99a-5p: A Potential Biomarker to Predict Early Head and Neck Squamous Cell Carcinoma
by: Qiang Huang, et al.
Published: (2022) -
Extracellular Vesicles as Drug Delivery Systems in Cancer
by: Laia Hernandez-Oller, et al.
Published: (2020) -
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021) -
Extracellular Vesicles as Drug Delivery System for Cancer Therapy
by: Jin Wang, et al.
Published: (2024)